Charles River Laboratories | CRL - Loan Capital


Charles River Laboratories reported $2.62B in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Agilent USD 3.05B 1000K Mar/2026
Align Technology USD 0 0 Dec/2024
Bio-Rad Laboratories USD 803M 100K Jun/2026
Bruker USD 1.81B 151.8M Jun/2026
Cardinal Health USD 8.25B 102M Mar/2026
Charles River Laboratories USD 2.62B 43.15M Jun/2026
Cigna USD 29.09B 285M Jun/2026
Concord Medical Services Hldg CNY 2.47B 197.85M Dec/2025
CVS Health USD 59.45B 1.08B Jun/2026
Danaher USD 25.15B 7.59B Jun/2026
Dentsply International USD 2B 10M Jun/2026
Elevance Health USD 30.67B 99M Jun/2026
Humana USD 11.98B 295M Jun/2026
Illumina USD 1.49B 1000K Jun/2026
Incyte USD 28.42M 994K Jun/2026
Intrexon USD 0 198.67M Jun/2024
IQVIA Holdings USD 13.7B 284M Jun/2026
Laboratory Of America USD 5.92B 23.3M Jun/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Lonza CHF 3.88B 323M Dec/2025
McKesson USD 8.43B 3.17B Jun/2026
Merck EUR 10.8B 72M Mar/2026
Mettler Toledo International USD 2.04B 116.92M Jun/2026
Novartis USD 37.49B 42M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Quest Diagnostics USD 5.63B 477M Jun/2026
Revvity USD 2.63B 1.02M Jun/2026
Thermo Fisher Scientific USD 39.18B 890M Jun/2026
United Therapeutics USD 100M 100M Jun/2024
UnitedHealth USD 69.5B 1.94B Jun/2026
Veradigm USD 200.4M 69K Dec/2022
Waters USD 5.09B 129M Jun/2026
West Pharmaceutical Services USD 202.9M 100K Jun/2026